Global Procalcitonin (PCT) Assay Market Growth 2026-2032
The global Procalcitonin (PCT) Assay market size is predicted to grow from US$ 357 million in 2025 to US$ 652 million in 2032; it is expected to grow at a CAGR of 9.0% from 2026 to 2032.
Procalcitonin (PCT) Assay is an in vitro diagnostic test used to quantitatively measure procalcitonin levels in serum, plasma, or whole blood specimens to aid in the risk assessment, diagnosis, and monitoring of patients with suspected sepsis. PCT is a biomarker that increases significantly during bacterial infections but remains low during viral infections or inflammatory responses, making it highly specific for bacterial sepsis.
The upstream segment includes raw material suppliers of monoclonal antibodies, latex particles, chemiluminescent substrates, fluorescent labels, microplates, and other immunoassay components. The midstream segment encompasses IVD assay development, manufacturing, regulatory approval (FDA 510(k), CE marking, NMPA registration), and quality control performed by diagnostic manufacturers. PCT assays are categorized by technology platform into chemiluminescent immunoassay (CLIA), enzyme-linked fluorescent assay (ELFA), fluorescence immunochromatography (POCT), and enzyme-linked immunosorbent assay (ELISA); by sample type into serum, plasma, and whole blood assays; by application into sepsis risk assessment, antibiotic therapy guidance, and prognostic monitoring.
The downstream segment serves hospital clinical laboratories, ICUs, emergency departments, and reference labs through direct sales, distributors, and group purchasing organizations.
The global average selling price for procalcitonin assays is approximately US$10.50 per test, with annual sales volume reaching 34,800k tests in 2025. The industry maintains gross margins between 40% and 65%, reflecting the high-value nature of critical care diagnostics and ongoing technology premium.
The global procalcitonin (PCT) assay market is experiencing accelerated growth, driven by increasing awareness of antimicrobial stewardship, rising incidence of sepsis worldwide, and the expanding clinical utility of PCT beyond initial diagnosis into antibiotic therapy monitoring and prognosis assessment. PCT has emerged as the gold standard biomarker for differentiating bacterial from viral infections, enabling more targeted antibiotic use.
A notable trend reshaping the market is the shift toward high-throughput automated platforms. Historically, PCT testing was limited to specialized platforms such as Thermo Fisher's Kryptor and bioM?rieux's VIDAS, which were not widely available in routine clinical chemistry labs. The recent FDA clearance of PCT assays for major automated platforms has significantly expanded market accessibility, enabling more hospitals to offer rapid, cost-effective PCT testing. This automation trend has driven down testing costs while improving turnaround times.
Another significant development is the increasing adoption of PCT-guided antibiotic stewardship protocols. Clinical studies have demonstrated that PCT monitoring enables earlier discontinuation of unnecessary antibiotics, reducing treatment costs, hospital-acquired complications, and antimicrobial resistance. Regulatory bodies have expanded approved clinical claims to include serial PCT measurements over days as a gauge of patient response to therapy, further strengthening PCT's role in antimicrobial stewardship programs.
LP Information, Inc. (LPI) ' newest research report, the ?Procalcitonin (PCT) Assay Industry Forecast? looks at past sales and reviews total world Procalcitonin (PCT) Assay sales in 2025, providing a comprehensive analysis by region and market sector of projected Procalcitonin (PCT) Assay sales for 2026 through 2032. With Procalcitonin (PCT) Assay sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Procalcitonin (PCT) Assay industry.
This Insight Report provides a comprehensive analysis of the global Procalcitonin (PCT) Assay landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Procalcitonin (PCT) Assay portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Procalcitonin (PCT) Assay market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Procalcitonin (PCT) Assay and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Procalcitonin (PCT) Assay.
This report presents a comprehensive overview, market shares, and growth opportunities of Procalcitonin (PCT) Assay market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Procalcitonin (PCT) Assay market?
What factors are driving Procalcitonin (PCT) Assay market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Procalcitonin (PCT) Assay market opportunities vary by end market size?
How does Procalcitonin (PCT) Assay break out by Type, by Application?
Procalcitonin (PCT) Assay is an in vitro diagnostic test used to quantitatively measure procalcitonin levels in serum, plasma, or whole blood specimens to aid in the risk assessment, diagnosis, and monitoring of patients with suspected sepsis. PCT is a biomarker that increases significantly during bacterial infections but remains low during viral infections or inflammatory responses, making it highly specific for bacterial sepsis.
The upstream segment includes raw material suppliers of monoclonal antibodies, latex particles, chemiluminescent substrates, fluorescent labels, microplates, and other immunoassay components. The midstream segment encompasses IVD assay development, manufacturing, regulatory approval (FDA 510(k), CE marking, NMPA registration), and quality control performed by diagnostic manufacturers. PCT assays are categorized by technology platform into chemiluminescent immunoassay (CLIA), enzyme-linked fluorescent assay (ELFA), fluorescence immunochromatography (POCT), and enzyme-linked immunosorbent assay (ELISA); by sample type into serum, plasma, and whole blood assays; by application into sepsis risk assessment, antibiotic therapy guidance, and prognostic monitoring.
The downstream segment serves hospital clinical laboratories, ICUs, emergency departments, and reference labs through direct sales, distributors, and group purchasing organizations.
The global average selling price for procalcitonin assays is approximately US$10.50 per test, with annual sales volume reaching 34,800k tests in 2025. The industry maintains gross margins between 40% and 65%, reflecting the high-value nature of critical care diagnostics and ongoing technology premium.
The global procalcitonin (PCT) assay market is experiencing accelerated growth, driven by increasing awareness of antimicrobial stewardship, rising incidence of sepsis worldwide, and the expanding clinical utility of PCT beyond initial diagnosis into antibiotic therapy monitoring and prognosis assessment. PCT has emerged as the gold standard biomarker for differentiating bacterial from viral infections, enabling more targeted antibiotic use.
A notable trend reshaping the market is the shift toward high-throughput automated platforms. Historically, PCT testing was limited to specialized platforms such as Thermo Fisher's Kryptor and bioM?rieux's VIDAS, which were not widely available in routine clinical chemistry labs. The recent FDA clearance of PCT assays for major automated platforms has significantly expanded market accessibility, enabling more hospitals to offer rapid, cost-effective PCT testing. This automation trend has driven down testing costs while improving turnaround times.
Another significant development is the increasing adoption of PCT-guided antibiotic stewardship protocols. Clinical studies have demonstrated that PCT monitoring enables earlier discontinuation of unnecessary antibiotics, reducing treatment costs, hospital-acquired complications, and antimicrobial resistance. Regulatory bodies have expanded approved clinical claims to include serial PCT measurements over days as a gauge of patient response to therapy, further strengthening PCT's role in antimicrobial stewardship programs.
LP Information, Inc. (LPI) ' newest research report, the ?Procalcitonin (PCT) Assay Industry Forecast? looks at past sales and reviews total world Procalcitonin (PCT) Assay sales in 2025, providing a comprehensive analysis by region and market sector of projected Procalcitonin (PCT) Assay sales for 2026 through 2032. With Procalcitonin (PCT) Assay sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Procalcitonin (PCT) Assay industry.
This Insight Report provides a comprehensive analysis of the global Procalcitonin (PCT) Assay landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Procalcitonin (PCT) Assay portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Procalcitonin (PCT) Assay market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Procalcitonin (PCT) Assay and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Procalcitonin (PCT) Assay.
This report presents a comprehensive overview, market shares, and growth opportunities of Procalcitonin (PCT) Assay market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Serum
- Plasma (EDTA/Lithium Heparin)
- Whole Blood
- Fully Automated (High-Throughput)
- Semi-Automated
- Manual / Low-Volume
- Class II (FDA)
- Class B/C (IVDR)
- Class III (NMPA)
- Hospital Clinical Laboratories
- Intensive Care Units (ICUs)
- Emergency Departments
- Reference Laboratories
- Point-of-Care Settings
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Thermo Fisher Scientific Inc.
- bioM?rieux S.A.
- F. Hoffmann-La Roche Ltd
- Fujirebio Inc.
- Abbott Laboratories
- Siemens Healthineers
- Becton, Dickinson and Company
- Danaher Corporation (Beckman Coulter)
- Guangzhou Wondfo Biotech Co., Ltd.
- Getein Biotech, Inc.
- Shanghai Outdo Biotech Co., Ltd.
- Beijing Biosis Healing Biological Technology Co., Ltd.
- Snibe Diagnostic
- Bioscience (Tianjin) Biotechnology Co., Ltd.
- Changchun BCHT Biotechnology Co.
- Ningbo Medicalsystem Biotechnology Co., Ltd.
What is the 10-year outlook for the global Procalcitonin (PCT) Assay market?
What factors are driving Procalcitonin (PCT) Assay market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Procalcitonin (PCT) Assay market opportunities vary by end market size?
How does Procalcitonin (PCT) Assay break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Procalcitonin (PCT) Assay Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Procalcitonin (PCT) Assay by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Procalcitonin (PCT) Assay by Country/Region, 2021, 2025 & 2032
2.2 Procalcitonin (PCT) Assay Segment by Type
2.2.1 Serum
2.2.2 Plasma (EDTA/Lithium Heparin)
2.2.3 Whole Blood
2.2.4 Procalcitonin (PCT) Assay Sales by Type
2.2.4.1 Global Procalcitonin (PCT) Assay Sales Market Share by Type (2021-2026)
2.2.4.2 Global Procalcitonin (PCT) Assay Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Procalcitonin (PCT) Assay Sale Price by Type (2021-2026)
2.3 Procalcitonin (PCT) Assay Segment by Automation Level
2.3.1 Fully Automated (High-Throughput)
2.3.2 Semi-Automated
2.3.3 Manual / Low-Volume
2.3.4 Procalcitonin (PCT) Assay Sales by Automation Level
2.3.4.1 Global Procalcitonin (PCT) Assay Sales Market Share by Automation Level (2021-2026)
2.3.4.2 Global Procalcitonin (PCT) Assay Revenue and Market Share by Automation Level (2021-2026)
2.3.4.3 Global Procalcitonin (PCT) Assay Sale Price by Automation Level (2021-2026)
2.4 Procalcitonin (PCT) Assay Segment by Regulatory Class
2.4.1 Class II (FDA)
2.4.2 Class B/C (IVDR)
2.4.3 Class III (NMPA)
2.4.4 Procalcitonin (PCT) Assay Sales by Regulatory Class
2.4.4.1 Global Procalcitonin (PCT) Assay Sales Market Share by Regulatory Class (2021-2026)
2.4.4.2 Global Procalcitonin (PCT) Assay Revenue and Market Share by Regulatory Class (2021-2026)
2.4.4.3 Global Procalcitonin (PCT) Assay Sale Price by Regulatory Class (2021-2026)
2.5 Procalcitonin (PCT) Assay Segment by Application
2.5.1 Hospital Clinical Laboratories
2.5.2 Intensive Care Units (ICUs)
2.5.3 Emergency Departments
2.5.4 Reference Laboratories
2.5.5 Point-of-Care Settings
2.5.6 Procalcitonin (PCT) Assay Sales by Application
2.5.6.1 Global Procalcitonin (PCT) Assay Sale Market Share by Application (2021-2026)
2.5.6.2 Global Procalcitonin (PCT) Assay Revenue and Market Share by Application (2021-2026)
2.5.6.3 Global Procalcitonin (PCT) Assay Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Procalcitonin (PCT) Assay Breakdown Data by Company
3.1.1 Global Procalcitonin (PCT) Assay Annual Sales by Company (2021-2026)
3.1.2 Global Procalcitonin (PCT) Assay Sales Market Share by Company (2021-2026)
3.2 Global Procalcitonin (PCT) Assay Annual Revenue by Company (2021-2026)
3.2.1 Global Procalcitonin (PCT) Assay Revenue by Company (2021-2026)
3.2.2 Global Procalcitonin (PCT) Assay Revenue Market Share by Company (2021-2026)
3.3 Global Procalcitonin (PCT) Assay Sale Price by Company
3.4 Key Manufacturers Procalcitonin (PCT) Assay Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Procalcitonin (PCT) Assay Product Location Distribution
3.4.2 Players Procalcitonin (PCT) Assay Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PROCALCITONIN (PCT) ASSAY BY GEOGRAPHIC REGION
4.1 World Historic Procalcitonin (PCT) Assay Market Size by Geographic Region (2021-2026)
4.1.1 Global Procalcitonin (PCT) Assay Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Procalcitonin (PCT) Assay Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Procalcitonin (PCT) Assay Market Size by Country/Region (2021-2026)
4.2.1 Global Procalcitonin (PCT) Assay Annual Sales by Country/Region (2021-2026)
4.2.2 Global Procalcitonin (PCT) Assay Annual Revenue by Country/Region (2021-2026)
4.3 Americas Procalcitonin (PCT) Assay Sales Growth
4.4 APAC Procalcitonin (PCT) Assay Sales Growth
4.5 Europe Procalcitonin (PCT) Assay Sales Growth
4.6 Middle East & Africa Procalcitonin (PCT) Assay Sales Growth
5 AMERICAS
5.1 Americas Procalcitonin (PCT) Assay Sales by Country
5.1.1 Americas Procalcitonin (PCT) Assay Sales by Country (2021-2026)
5.1.2 Americas Procalcitonin (PCT) Assay Revenue by Country (2021-2026)
5.2 Americas Procalcitonin (PCT) Assay Sales by Type (2021-2026)
5.3 Americas Procalcitonin (PCT) Assay Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Procalcitonin (PCT) Assay Sales by Region
6.1.1 APAC Procalcitonin (PCT) Assay Sales by Region (2021-2026)
6.1.2 APAC Procalcitonin (PCT) Assay Revenue by Region (2021-2026)
6.2 APAC Procalcitonin (PCT) Assay Sales by Type (2021-2026)
6.3 APAC Procalcitonin (PCT) Assay Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Procalcitonin (PCT) Assay by Country
7.1.1 Europe Procalcitonin (PCT) Assay Sales by Country (2021-2026)
7.1.2 Europe Procalcitonin (PCT) Assay Revenue by Country (2021-2026)
7.2 Europe Procalcitonin (PCT) Assay Sales by Type (2021-2026)
7.3 Europe Procalcitonin (PCT) Assay Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Procalcitonin (PCT) Assay by Country
8.1.1 Middle East & Africa Procalcitonin (PCT) Assay Sales by Country (2021-2026)
8.1.2 Middle East & Africa Procalcitonin (PCT) Assay Revenue by Country (2021-2026)
8.2 Middle East & Africa Procalcitonin (PCT) Assay Sales by Type (2021-2026)
8.3 Middle East & Africa Procalcitonin (PCT) Assay Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Procalcitonin (PCT) Assay
10.3 Manufacturing Process Analysis of Procalcitonin (PCT) Assay
10.4 Industry Chain Structure of Procalcitonin (PCT) Assay
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Procalcitonin (PCT) Assay Distributors
11.3 Procalcitonin (PCT) Assay Customer
12 WORLD FORECAST REVIEW FOR PROCALCITONIN (PCT) ASSAY BY GEOGRAPHIC REGION
12.1 Global Procalcitonin (PCT) Assay Market Size Forecast by Region
12.1.1 Global Procalcitonin (PCT) Assay Forecast by Region (2027-2032)
12.1.2 Global Procalcitonin (PCT) Assay Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Procalcitonin (PCT) Assay Forecast by Type (2027-2032)
12.7 Global Procalcitonin (PCT) Assay Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Thermo Fisher Scientific Inc.
13.1.1 Thermo Fisher Scientific Inc. Company Information
13.1.2 Thermo Fisher Scientific Inc. Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.1.3 Thermo Fisher Scientific Inc. Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Thermo Fisher Scientific Inc. Main Business Overview
13.1.5 Thermo Fisher Scientific Inc. Latest Developments
13.2 bioM?rieux S.A.
13.2.1 bioM?rieux S.A. Company Information
13.2.2 bioM?rieux S.A. Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.2.3 bioM?rieux S.A. Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 bioM?rieux S.A. Main Business Overview
13.2.5 bioM?rieux S.A. Latest Developments
13.3 F. Hoffmann-La Roche Ltd
13.3.1 F. Hoffmann-La Roche Ltd Company Information
13.3.2 F. Hoffmann-La Roche Ltd Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.3.3 F. Hoffmann-La Roche Ltd Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 F. Hoffmann-La Roche Ltd Main Business Overview
13.3.5 F. Hoffmann-La Roche Ltd Latest Developments
13.4 Fujirebio Inc.
13.4.1 Fujirebio Inc. Company Information
13.4.2 Fujirebio Inc. Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.4.3 Fujirebio Inc. Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Fujirebio Inc. Main Business Overview
13.4.5 Fujirebio Inc. Latest Developments
13.5 Abbott Laboratories
13.5.1 Abbott Laboratories Company Information
13.5.2 Abbott Laboratories Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.5.3 Abbott Laboratories Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Abbott Laboratories Main Business Overview
13.5.5 Abbott Laboratories Latest Developments
13.6 Siemens Healthineers
13.6.1 Siemens Healthineers Company Information
13.6.2 Siemens Healthineers Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.6.3 Siemens Healthineers Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Siemens Healthineers Main Business Overview
13.6.5 Siemens Healthineers Latest Developments
13.7 Becton, Dickinson and Company
13.7.1 Becton, Dickinson and Company Company Information
13.7.2 Becton, Dickinson and Company Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.7.3 Becton, Dickinson and Company Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Becton, Dickinson and Company Main Business Overview
13.7.5 Becton, Dickinson and Company Latest Developments
13.8 Danaher Corporation (Beckman Coulter)
13.8.1 Danaher Corporation (Beckman Coulter) Company Information
13.8.2 Danaher Corporation (Beckman Coulter) Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.8.3 Danaher Corporation (Beckman Coulter) Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Danaher Corporation (Beckman Coulter) Main Business Overview
13.8.5 Danaher Corporation (Beckman Coulter) Latest Developments
13.9 Guangzhou Wondfo Biotech Co., Ltd.
13.9.1 Guangzhou Wondfo Biotech Co., Ltd. Company Information
13.9.2 Guangzhou Wondfo Biotech Co., Ltd. Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.9.3 Guangzhou Wondfo Biotech Co., Ltd. Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Guangzhou Wondfo Biotech Co., Ltd. Main Business Overview
13.9.5 Guangzhou Wondfo Biotech Co., Ltd. Latest Developments
13.10 Getein Biotech, Inc.
13.10.1 Getein Biotech, Inc. Company Information
13.10.2 Getein Biotech, Inc. Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.10.3 Getein Biotech, Inc. Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Getein Biotech, Inc. Main Business Overview
13.10.5 Getein Biotech, Inc. Latest Developments
13.11 Shanghai Outdo Biotech Co., Ltd.
13.11.1 Shanghai Outdo Biotech Co., Ltd. Company Information
13.11.2 Shanghai Outdo Biotech Co., Ltd. Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.11.3 Shanghai Outdo Biotech Co., Ltd. Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Shanghai Outdo Biotech Co., Ltd. Main Business Overview
13.11.5 Shanghai Outdo Biotech Co., Ltd. Latest Developments
13.12 Beijing Biosis Healing Biological Technology Co., Ltd.
13.12.1 Beijing Biosis Healing Biological Technology Co., Ltd. Company Information
13.12.2 Beijing Biosis Healing Biological Technology Co., Ltd. Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.12.3 Beijing Biosis Healing Biological Technology Co., Ltd. Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Beijing Biosis Healing Biological Technology Co., Ltd. Main Business Overview
13.12.5 Beijing Biosis Healing Biological Technology Co., Ltd. Latest Developments
13.13 Snibe Diagnostic
13.13.1 Snibe Diagnostic Company Information
13.13.2 Snibe Diagnostic Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.13.3 Snibe Diagnostic Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Snibe Diagnostic Main Business Overview
13.13.5 Snibe Diagnostic Latest Developments
13.14 Bioscience (Tianjin) Biotechnology Co., Ltd.
13.14.1 Bioscience (Tianjin) Biotechnology Co., Ltd. Company Information
13.14.2 Bioscience (Tianjin) Biotechnology Co., Ltd. Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.14.3 Bioscience (Tianjin) Biotechnology Co., Ltd. Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Bioscience (Tianjin) Biotechnology Co., Ltd. Main Business Overview
13.14.5 Bioscience (Tianjin) Biotechnology Co., Ltd. Latest Developments
13.15 Changchun BCHT Biotechnology Co.
13.15.1 Changchun BCHT Biotechnology Co. Company Information
13.15.2 Changchun BCHT Biotechnology Co. Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.15.3 Changchun BCHT Biotechnology Co. Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Changchun BCHT Biotechnology Co. Main Business Overview
13.15.5 Changchun BCHT Biotechnology Co. Latest Developments
13.16 Ningbo Medicalsystem Biotechnology Co., Ltd.
13.16.1 Ningbo Medicalsystem Biotechnology Co., Ltd. Company Information
13.16.2 Ningbo Medicalsystem Biotechnology Co., Ltd. Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.16.3 Ningbo Medicalsystem Biotechnology Co., Ltd. Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Ningbo Medicalsystem Biotechnology Co., Ltd. Main Business Overview
13.16.5 Ningbo Medicalsystem Biotechnology Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Procalcitonin (PCT) Assay Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Procalcitonin (PCT) Assay by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Procalcitonin (PCT) Assay by Country/Region, 2021, 2025 & 2032
2.2 Procalcitonin (PCT) Assay Segment by Type
2.2.1 Serum
2.2.2 Plasma (EDTA/Lithium Heparin)
2.2.3 Whole Blood
2.2.4 Procalcitonin (PCT) Assay Sales by Type
2.2.4.1 Global Procalcitonin (PCT) Assay Sales Market Share by Type (2021-2026)
2.2.4.2 Global Procalcitonin (PCT) Assay Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Procalcitonin (PCT) Assay Sale Price by Type (2021-2026)
2.3 Procalcitonin (PCT) Assay Segment by Automation Level
2.3.1 Fully Automated (High-Throughput)
2.3.2 Semi-Automated
2.3.3 Manual / Low-Volume
2.3.4 Procalcitonin (PCT) Assay Sales by Automation Level
2.3.4.1 Global Procalcitonin (PCT) Assay Sales Market Share by Automation Level (2021-2026)
2.3.4.2 Global Procalcitonin (PCT) Assay Revenue and Market Share by Automation Level (2021-2026)
2.3.4.3 Global Procalcitonin (PCT) Assay Sale Price by Automation Level (2021-2026)
2.4 Procalcitonin (PCT) Assay Segment by Regulatory Class
2.4.1 Class II (FDA)
2.4.2 Class B/C (IVDR)
2.4.3 Class III (NMPA)
2.4.4 Procalcitonin (PCT) Assay Sales by Regulatory Class
2.4.4.1 Global Procalcitonin (PCT) Assay Sales Market Share by Regulatory Class (2021-2026)
2.4.4.2 Global Procalcitonin (PCT) Assay Revenue and Market Share by Regulatory Class (2021-2026)
2.4.4.3 Global Procalcitonin (PCT) Assay Sale Price by Regulatory Class (2021-2026)
2.5 Procalcitonin (PCT) Assay Segment by Application
2.5.1 Hospital Clinical Laboratories
2.5.2 Intensive Care Units (ICUs)
2.5.3 Emergency Departments
2.5.4 Reference Laboratories
2.5.5 Point-of-Care Settings
2.5.6 Procalcitonin (PCT) Assay Sales by Application
2.5.6.1 Global Procalcitonin (PCT) Assay Sale Market Share by Application (2021-2026)
2.5.6.2 Global Procalcitonin (PCT) Assay Revenue and Market Share by Application (2021-2026)
2.5.6.3 Global Procalcitonin (PCT) Assay Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Procalcitonin (PCT) Assay Breakdown Data by Company
3.1.1 Global Procalcitonin (PCT) Assay Annual Sales by Company (2021-2026)
3.1.2 Global Procalcitonin (PCT) Assay Sales Market Share by Company (2021-2026)
3.2 Global Procalcitonin (PCT) Assay Annual Revenue by Company (2021-2026)
3.2.1 Global Procalcitonin (PCT) Assay Revenue by Company (2021-2026)
3.2.2 Global Procalcitonin (PCT) Assay Revenue Market Share by Company (2021-2026)
3.3 Global Procalcitonin (PCT) Assay Sale Price by Company
3.4 Key Manufacturers Procalcitonin (PCT) Assay Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Procalcitonin (PCT) Assay Product Location Distribution
3.4.2 Players Procalcitonin (PCT) Assay Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PROCALCITONIN (PCT) ASSAY BY GEOGRAPHIC REGION
4.1 World Historic Procalcitonin (PCT) Assay Market Size by Geographic Region (2021-2026)
4.1.1 Global Procalcitonin (PCT) Assay Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Procalcitonin (PCT) Assay Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Procalcitonin (PCT) Assay Market Size by Country/Region (2021-2026)
4.2.1 Global Procalcitonin (PCT) Assay Annual Sales by Country/Region (2021-2026)
4.2.2 Global Procalcitonin (PCT) Assay Annual Revenue by Country/Region (2021-2026)
4.3 Americas Procalcitonin (PCT) Assay Sales Growth
4.4 APAC Procalcitonin (PCT) Assay Sales Growth
4.5 Europe Procalcitonin (PCT) Assay Sales Growth
4.6 Middle East & Africa Procalcitonin (PCT) Assay Sales Growth
5 AMERICAS
5.1 Americas Procalcitonin (PCT) Assay Sales by Country
5.1.1 Americas Procalcitonin (PCT) Assay Sales by Country (2021-2026)
5.1.2 Americas Procalcitonin (PCT) Assay Revenue by Country (2021-2026)
5.2 Americas Procalcitonin (PCT) Assay Sales by Type (2021-2026)
5.3 Americas Procalcitonin (PCT) Assay Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Procalcitonin (PCT) Assay Sales by Region
6.1.1 APAC Procalcitonin (PCT) Assay Sales by Region (2021-2026)
6.1.2 APAC Procalcitonin (PCT) Assay Revenue by Region (2021-2026)
6.2 APAC Procalcitonin (PCT) Assay Sales by Type (2021-2026)
6.3 APAC Procalcitonin (PCT) Assay Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Procalcitonin (PCT) Assay by Country
7.1.1 Europe Procalcitonin (PCT) Assay Sales by Country (2021-2026)
7.1.2 Europe Procalcitonin (PCT) Assay Revenue by Country (2021-2026)
7.2 Europe Procalcitonin (PCT) Assay Sales by Type (2021-2026)
7.3 Europe Procalcitonin (PCT) Assay Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Procalcitonin (PCT) Assay by Country
8.1.1 Middle East & Africa Procalcitonin (PCT) Assay Sales by Country (2021-2026)
8.1.2 Middle East & Africa Procalcitonin (PCT) Assay Revenue by Country (2021-2026)
8.2 Middle East & Africa Procalcitonin (PCT) Assay Sales by Type (2021-2026)
8.3 Middle East & Africa Procalcitonin (PCT) Assay Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Procalcitonin (PCT) Assay
10.3 Manufacturing Process Analysis of Procalcitonin (PCT) Assay
10.4 Industry Chain Structure of Procalcitonin (PCT) Assay
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Procalcitonin (PCT) Assay Distributors
11.3 Procalcitonin (PCT) Assay Customer
12 WORLD FORECAST REVIEW FOR PROCALCITONIN (PCT) ASSAY BY GEOGRAPHIC REGION
12.1 Global Procalcitonin (PCT) Assay Market Size Forecast by Region
12.1.1 Global Procalcitonin (PCT) Assay Forecast by Region (2027-2032)
12.1.2 Global Procalcitonin (PCT) Assay Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Procalcitonin (PCT) Assay Forecast by Type (2027-2032)
12.7 Global Procalcitonin (PCT) Assay Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Thermo Fisher Scientific Inc.
13.1.1 Thermo Fisher Scientific Inc. Company Information
13.1.2 Thermo Fisher Scientific Inc. Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.1.3 Thermo Fisher Scientific Inc. Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Thermo Fisher Scientific Inc. Main Business Overview
13.1.5 Thermo Fisher Scientific Inc. Latest Developments
13.2 bioM?rieux S.A.
13.2.1 bioM?rieux S.A. Company Information
13.2.2 bioM?rieux S.A. Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.2.3 bioM?rieux S.A. Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 bioM?rieux S.A. Main Business Overview
13.2.5 bioM?rieux S.A. Latest Developments
13.3 F. Hoffmann-La Roche Ltd
13.3.1 F. Hoffmann-La Roche Ltd Company Information
13.3.2 F. Hoffmann-La Roche Ltd Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.3.3 F. Hoffmann-La Roche Ltd Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 F. Hoffmann-La Roche Ltd Main Business Overview
13.3.5 F. Hoffmann-La Roche Ltd Latest Developments
13.4 Fujirebio Inc.
13.4.1 Fujirebio Inc. Company Information
13.4.2 Fujirebio Inc. Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.4.3 Fujirebio Inc. Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Fujirebio Inc. Main Business Overview
13.4.5 Fujirebio Inc. Latest Developments
13.5 Abbott Laboratories
13.5.1 Abbott Laboratories Company Information
13.5.2 Abbott Laboratories Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.5.3 Abbott Laboratories Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Abbott Laboratories Main Business Overview
13.5.5 Abbott Laboratories Latest Developments
13.6 Siemens Healthineers
13.6.1 Siemens Healthineers Company Information
13.6.2 Siemens Healthineers Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.6.3 Siemens Healthineers Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Siemens Healthineers Main Business Overview
13.6.5 Siemens Healthineers Latest Developments
13.7 Becton, Dickinson and Company
13.7.1 Becton, Dickinson and Company Company Information
13.7.2 Becton, Dickinson and Company Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.7.3 Becton, Dickinson and Company Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Becton, Dickinson and Company Main Business Overview
13.7.5 Becton, Dickinson and Company Latest Developments
13.8 Danaher Corporation (Beckman Coulter)
13.8.1 Danaher Corporation (Beckman Coulter) Company Information
13.8.2 Danaher Corporation (Beckman Coulter) Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.8.3 Danaher Corporation (Beckman Coulter) Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Danaher Corporation (Beckman Coulter) Main Business Overview
13.8.5 Danaher Corporation (Beckman Coulter) Latest Developments
13.9 Guangzhou Wondfo Biotech Co., Ltd.
13.9.1 Guangzhou Wondfo Biotech Co., Ltd. Company Information
13.9.2 Guangzhou Wondfo Biotech Co., Ltd. Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.9.3 Guangzhou Wondfo Biotech Co., Ltd. Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Guangzhou Wondfo Biotech Co., Ltd. Main Business Overview
13.9.5 Guangzhou Wondfo Biotech Co., Ltd. Latest Developments
13.10 Getein Biotech, Inc.
13.10.1 Getein Biotech, Inc. Company Information
13.10.2 Getein Biotech, Inc. Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.10.3 Getein Biotech, Inc. Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Getein Biotech, Inc. Main Business Overview
13.10.5 Getein Biotech, Inc. Latest Developments
13.11 Shanghai Outdo Biotech Co., Ltd.
13.11.1 Shanghai Outdo Biotech Co., Ltd. Company Information
13.11.2 Shanghai Outdo Biotech Co., Ltd. Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.11.3 Shanghai Outdo Biotech Co., Ltd. Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Shanghai Outdo Biotech Co., Ltd. Main Business Overview
13.11.5 Shanghai Outdo Biotech Co., Ltd. Latest Developments
13.12 Beijing Biosis Healing Biological Technology Co., Ltd.
13.12.1 Beijing Biosis Healing Biological Technology Co., Ltd. Company Information
13.12.2 Beijing Biosis Healing Biological Technology Co., Ltd. Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.12.3 Beijing Biosis Healing Biological Technology Co., Ltd. Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Beijing Biosis Healing Biological Technology Co., Ltd. Main Business Overview
13.12.5 Beijing Biosis Healing Biological Technology Co., Ltd. Latest Developments
13.13 Snibe Diagnostic
13.13.1 Snibe Diagnostic Company Information
13.13.2 Snibe Diagnostic Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.13.3 Snibe Diagnostic Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Snibe Diagnostic Main Business Overview
13.13.5 Snibe Diagnostic Latest Developments
13.14 Bioscience (Tianjin) Biotechnology Co., Ltd.
13.14.1 Bioscience (Tianjin) Biotechnology Co., Ltd. Company Information
13.14.2 Bioscience (Tianjin) Biotechnology Co., Ltd. Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.14.3 Bioscience (Tianjin) Biotechnology Co., Ltd. Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Bioscience (Tianjin) Biotechnology Co., Ltd. Main Business Overview
13.14.5 Bioscience (Tianjin) Biotechnology Co., Ltd. Latest Developments
13.15 Changchun BCHT Biotechnology Co.
13.15.1 Changchun BCHT Biotechnology Co. Company Information
13.15.2 Changchun BCHT Biotechnology Co. Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.15.3 Changchun BCHT Biotechnology Co. Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Changchun BCHT Biotechnology Co. Main Business Overview
13.15.5 Changchun BCHT Biotechnology Co. Latest Developments
13.16 Ningbo Medicalsystem Biotechnology Co., Ltd.
13.16.1 Ningbo Medicalsystem Biotechnology Co., Ltd. Company Information
13.16.2 Ningbo Medicalsystem Biotechnology Co., Ltd. Procalcitonin (PCT) Assay Product Portfolios and Specifications
13.16.3 Ningbo Medicalsystem Biotechnology Co., Ltd. Procalcitonin (PCT) Assay Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Ningbo Medicalsystem Biotechnology Co., Ltd. Main Business Overview
13.16.5 Ningbo Medicalsystem Biotechnology Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Procalcitonin (PCT) Assay Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Procalcitonin (PCT) Assay Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Serum
Table 4. Major Players of Plasma (EDTA/Lithium Heparin)
Table 5. Major Players of Whole Blood
Table 6. Global Procalcitonin (PCT) Assay Sales by Type (2021-2026) & (K Tests)
Table 7. Global Procalcitonin (PCT) Assay Sales Market Share by Type (2021-2026)
Table 8. Global Procalcitonin (PCT) Assay Revenue by Type (2021-2026) & ($ million)
Table 9. Global Procalcitonin (PCT) Assay Revenue Market Share by Type (2021-2026)
Table 10. Global Procalcitonin (PCT) Assay Sale Price by Type (2021-2026) & (US$/Test)
Table 11. Major Players of Fully Automated (High-Throughput)
Table 12. Major Players of Semi-Automated
Table 13. Major Players of Manual / Low-Volume
Table 14. Global Procalcitonin (PCT) Assay Sales by Automation Level (2021-2026) & (K Tests)
Table 15. Global Procalcitonin (PCT) Assay Sales Market Share by Automation Level (2021-2026)
Table 16. Global Procalcitonin (PCT) Assay Revenue by Automation Level (2021-2026) & ($ million)
Table 17. Global Procalcitonin (PCT) Assay Revenue Market Share by Automation Level (2021-2026)
Table 18. Global Procalcitonin (PCT) Assay Sale Price by Automation Level (2021-2026) & (US$/Test)
Table 19. Major Players of Class II (FDA)
Table 20. Major Players of Class B/C (IVDR)
Table 21. Major Players of Class III (NMPA)
Table 22. Global Procalcitonin (PCT) Assay Sales by Regulatory Class (2021-2026) & (K Tests)
Table 23. Global Procalcitonin (PCT) Assay Sales Market Share by Regulatory Class (2021-2026)
Table 24. Global Procalcitonin (PCT) Assay Revenue by Regulatory Class (2021-2026) & ($ million)
Table 25. Global Procalcitonin (PCT) Assay Revenue Market Share by Regulatory Class (2021-2026)
Table 26. Global Procalcitonin (PCT) Assay Sale Price by Regulatory Class (2021-2026) & (US$/Test)
Table 27. Global Procalcitonin (PCT) Assay Sale by Application (2021-2026) & (K Tests)
Table 28. Global Procalcitonin (PCT) Assay Sale Market Share by Application (2021-2026)
Table 29. Global Procalcitonin (PCT) Assay Revenue by Application (2021-2026) & ($ million)
Table 30. Global Procalcitonin (PCT) Assay Revenue Market Share by Application (2021-2026)
Table 31. Global Procalcitonin (PCT) Assay Sale Price by Application (2021-2026) & (US$/Test)
Table 32. Global Procalcitonin (PCT) Assay Sales by Company (2021-2026) & (K Tests)
Table 33. Global Procalcitonin (PCT) Assay Sales Market Share by Company (2021-2026)
Table 34. Global Procalcitonin (PCT) Assay Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Procalcitonin (PCT) Assay Revenue Market Share by Company (2021-2026)
Table 36. Global Procalcitonin (PCT) Assay Sale Price by Company (2021-2026) & (US$/Test)
Table 37. Key Manufacturers Procalcitonin (PCT) Assay Producing Area Distribution and Sales Area
Table 38. Players Procalcitonin (PCT) Assay Products Offered
Table 39. Procalcitonin (PCT) Assay Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Procalcitonin (PCT) Assay Sales by Geographic Region (2021-2026) & (K Tests)
Table 43. Global Procalcitonin (PCT) Assay Sales Market Share Geographic Region (2021-2026)
Table 44. Global Procalcitonin (PCT) Assay Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Procalcitonin (PCT) Assay Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Procalcitonin (PCT) Assay Sales by Country/Region (2021-2026) & (K Tests)
Table 47. Global Procalcitonin (PCT) Assay Sales Market Share by Country/Region (2021-2026)
Table 48. Global Procalcitonin (PCT) Assay Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Procalcitonin (PCT) Assay Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Procalcitonin (PCT) Assay Sales by Country (2021-2026) & (K Tests)
Table 51. Americas Procalcitonin (PCT) Assay Sales Market Share by Country (2021-2026)
Table 52. Americas Procalcitonin (PCT) Assay Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Procalcitonin (PCT) Assay Sales by Type (2021-2026) & (K Tests)
Table 54. Americas Procalcitonin (PCT) Assay Sales by Application (2021-2026) & (K Tests)
Table 55. APAC Procalcitonin (PCT) Assay Sales by Region (2021-2026) & (K Tests)
Table 56. APAC Procalcitonin (PCT) Assay Sales Market Share by Region (2021-2026)
Table 57. APAC Procalcitonin (PCT) Assay Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Procalcitonin (PCT) Assay Sales by Type (2021-2026) & (K Tests)
Table 59. APAC Procalcitonin (PCT) Assay Sales by Application (2021-2026) & (K Tests)
Table 60. Europe Procalcitonin (PCT) Assay Sales by Country (2021-2026) & (K Tests)
Table 61. Europe Procalcitonin (PCT) Assay Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Procalcitonin (PCT) Assay Sales by Type (2021-2026) & (K Tests)
Table 63. Europe Procalcitonin (PCT) Assay Sales by Application (2021-2026) & (K Tests)
Table 64. Middle East & Africa Procalcitonin (PCT) Assay Sales by Country (2021-2026) & (K Tests)
Table 65. Middle East & Africa Procalcitonin (PCT) Assay Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Procalcitonin (PCT) Assay Sales by Type (2021-2026) & (K Tests)
Table 67. Middle East & Africa Procalcitonin (PCT) Assay Sales by Application (2021-2026) & (K Tests)
Table 68. Key Market Drivers & Growth Opportunities of Procalcitonin (PCT) Assay
Table 69. Key Market Challenges & Risks of Procalcitonin (PCT) Assay
Table 70. Key Industry Trends of Procalcitonin (PCT) Assay
Table 71. Procalcitonin (PCT) Assay Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Procalcitonin (PCT) Assay Distributors List
Table 74. Procalcitonin (PCT) Assay Customer List
Table 75. Global Procalcitonin (PCT) Assay Sales Forecast by Region (2027-2032) & (K Tests)
Table 76. Global Procalcitonin (PCT) Assay Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Procalcitonin (PCT) Assay Sales Forecast by Country (2027-2032) & (K Tests)
Table 78. Americas Procalcitonin (PCT) Assay Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Procalcitonin (PCT) Assay Sales Forecast by Region (2027-2032) & (K Tests)
Table 80. APAC Procalcitonin (PCT) Assay Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Procalcitonin (PCT) Assay Sales Forecast by Country (2027-2032) & (K Tests)
Table 82. Europe Procalcitonin (PCT) Assay Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Procalcitonin (PCT) Assay Sales Forecast by Country (2027-2032) & (K Tests)
Table 84. Middle East & Africa Procalcitonin (PCT) Assay Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Procalcitonin (PCT) Assay Sales Forecast by Type (2027-2032) & (K Tests)
Table 86. Global Procalcitonin (PCT) Assay Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Procalcitonin (PCT) Assay Sales Forecast by Application (2027-2032) & (K Tests)
Table 88. Global Procalcitonin (PCT) Assay Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Thermo Fisher Scientific Inc. Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 90. Thermo Fisher Scientific Inc. Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 91. Thermo Fisher Scientific Inc. Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 92. Thermo Fisher Scientific Inc. Main Business
Table 93. Thermo Fisher Scientific Inc. Latest Developments
Table 94. bioM?rieux S.A. Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 95. bioM?rieux S.A. Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 96. bioM?rieux S.A. Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 97. bioM?rieux S.A. Main Business
Table 98. bioM?rieux S.A. Latest Developments
Table 99. F. Hoffmann-La Roche Ltd Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 100. F. Hoffmann-La Roche Ltd Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 101. F. Hoffmann-La Roche Ltd Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 102. F. Hoffmann-La Roche Ltd Main Business
Table 103. F. Hoffmann-La Roche Ltd Latest Developments
Table 104. Fujirebio Inc. Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 105. Fujirebio Inc. Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 106. Fujirebio Inc. Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 107. Fujirebio Inc. Main Business
Table 108. Fujirebio Inc. Latest Developments
Table 109. Abbott Laboratories Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 110. Abbott Laboratories Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 111. Abbott Laboratories Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 112. Abbott Laboratories Main Business
Table 113. Abbott Laboratories Latest Developments
Table 114. Siemens Healthineers Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 115. Siemens Healthineers Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 116. Siemens Healthineers Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 117. Siemens Healthineers Main Business
Table 118. Siemens Healthineers Latest Developments
Table 119. Becton, Dickinson and Company Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 120. Becton, Dickinson and Company Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 121. Becton, Dickinson and Company Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 122. Becton, Dickinson and Company Main Business
Table 123. Becton, Dickinson and Company Latest Developments
Table 124. Danaher Corporation (Beckman Coulter) Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 125. Danaher Corporation (Beckman Coulter) Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 126. Danaher Corporation (Beckman Coulter) Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 127. Danaher Corporation (Beckman Coulter) Main Business
Table 128. Danaher Corporation (Beckman Coulter) Latest Developments
Table 129. Guangzhou Wondfo Biotech Co., Ltd. Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 130. Guangzhou Wondfo Biotech Co., Ltd. Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 131. Guangzhou Wondfo Biotech Co., Ltd. Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 132. Guangzhou Wondfo Biotech Co., Ltd. Main Business
Table 133. Guangzhou Wondfo Biotech Co., Ltd. Latest Developments
Table 134. Getein Biotech, Inc. Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 135. Getein Biotech, Inc. Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 136. Getein Biotech, Inc. Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 137. Getein Biotech, Inc. Main Business
Table 138. Getein Biotech, Inc. Latest Developments
Table 139. Shanghai Outdo Biotech Co., Ltd. Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 140. Shanghai Outdo Biotech Co., Ltd. Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 141. Shanghai Outdo Biotech Co., Ltd. Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 142. Shanghai Outdo Biotech Co., Ltd. Main Business
Table 143. Shanghai Outdo Biotech Co., Ltd. Latest Developments
Table 144. Beijing Biosis Healing Biological Technology Co., Ltd. Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 145. Beijing Biosis Healing Biological Technology Co., Ltd. Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 146. Beijing Biosis Healing Biological Technology Co., Ltd. Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 147. Beijing Biosis Healing Biological Technology Co., Ltd. Main Business
Table 148. Beijing Biosis Healing Biological Technology Co., Ltd. Latest Developments
Table 149. Snibe Diagnostic Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 150. Snibe Diagnostic Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 151. Snibe Diagnostic Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 152. Snibe Diagnostic Main Business
Table 153. Snibe Diagnostic Latest Developments
Table 154. Bioscience (Tianjin) Biotechnology Co., Ltd. Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 155. Bioscience (Tianjin) Biotechnology Co., Ltd. Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 156. Bioscience (Tianjin) Biotechnology Co., Ltd. Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 157. Bioscience (Tianjin) Biotechnology Co., Ltd. Main Business
Table 158. Bioscience (Tianjin) Biotechnology Co., Ltd. Latest Developments
Table 159. Changchun BCHT Biotechnology Co. Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 160. Changchun BCHT Biotechnology Co. Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 161. Changchun BCHT Biotechnology Co. Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 162. Changchun BCHT Biotechnology Co. Main Business
Table 163. Changchun BCHT Biotechnology Co. Latest Developments
Table 164. Ningbo Medicalsystem Biotechnology Co., Ltd. Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 165. Ningbo Medicalsystem Biotechnology Co., Ltd. Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 166. Ningbo Medicalsystem Biotechnology Co., Ltd. Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 167. Ningbo Medicalsystem Biotechnology Co., Ltd. Main Business
Table 168. Ningbo Medicalsystem Biotechnology Co., Ltd. Latest Developments
Table 1. Procalcitonin (PCT) Assay Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Procalcitonin (PCT) Assay Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Serum
Table 4. Major Players of Plasma (EDTA/Lithium Heparin)
Table 5. Major Players of Whole Blood
Table 6. Global Procalcitonin (PCT) Assay Sales by Type (2021-2026) & (K Tests)
Table 7. Global Procalcitonin (PCT) Assay Sales Market Share by Type (2021-2026)
Table 8. Global Procalcitonin (PCT) Assay Revenue by Type (2021-2026) & ($ million)
Table 9. Global Procalcitonin (PCT) Assay Revenue Market Share by Type (2021-2026)
Table 10. Global Procalcitonin (PCT) Assay Sale Price by Type (2021-2026) & (US$/Test)
Table 11. Major Players of Fully Automated (High-Throughput)
Table 12. Major Players of Semi-Automated
Table 13. Major Players of Manual / Low-Volume
Table 14. Global Procalcitonin (PCT) Assay Sales by Automation Level (2021-2026) & (K Tests)
Table 15. Global Procalcitonin (PCT) Assay Sales Market Share by Automation Level (2021-2026)
Table 16. Global Procalcitonin (PCT) Assay Revenue by Automation Level (2021-2026) & ($ million)
Table 17. Global Procalcitonin (PCT) Assay Revenue Market Share by Automation Level (2021-2026)
Table 18. Global Procalcitonin (PCT) Assay Sale Price by Automation Level (2021-2026) & (US$/Test)
Table 19. Major Players of Class II (FDA)
Table 20. Major Players of Class B/C (IVDR)
Table 21. Major Players of Class III (NMPA)
Table 22. Global Procalcitonin (PCT) Assay Sales by Regulatory Class (2021-2026) & (K Tests)
Table 23. Global Procalcitonin (PCT) Assay Sales Market Share by Regulatory Class (2021-2026)
Table 24. Global Procalcitonin (PCT) Assay Revenue by Regulatory Class (2021-2026) & ($ million)
Table 25. Global Procalcitonin (PCT) Assay Revenue Market Share by Regulatory Class (2021-2026)
Table 26. Global Procalcitonin (PCT) Assay Sale Price by Regulatory Class (2021-2026) & (US$/Test)
Table 27. Global Procalcitonin (PCT) Assay Sale by Application (2021-2026) & (K Tests)
Table 28. Global Procalcitonin (PCT) Assay Sale Market Share by Application (2021-2026)
Table 29. Global Procalcitonin (PCT) Assay Revenue by Application (2021-2026) & ($ million)
Table 30. Global Procalcitonin (PCT) Assay Revenue Market Share by Application (2021-2026)
Table 31. Global Procalcitonin (PCT) Assay Sale Price by Application (2021-2026) & (US$/Test)
Table 32. Global Procalcitonin (PCT) Assay Sales by Company (2021-2026) & (K Tests)
Table 33. Global Procalcitonin (PCT) Assay Sales Market Share by Company (2021-2026)
Table 34. Global Procalcitonin (PCT) Assay Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Procalcitonin (PCT) Assay Revenue Market Share by Company (2021-2026)
Table 36. Global Procalcitonin (PCT) Assay Sale Price by Company (2021-2026) & (US$/Test)
Table 37. Key Manufacturers Procalcitonin (PCT) Assay Producing Area Distribution and Sales Area
Table 38. Players Procalcitonin (PCT) Assay Products Offered
Table 39. Procalcitonin (PCT) Assay Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Procalcitonin (PCT) Assay Sales by Geographic Region (2021-2026) & (K Tests)
Table 43. Global Procalcitonin (PCT) Assay Sales Market Share Geographic Region (2021-2026)
Table 44. Global Procalcitonin (PCT) Assay Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Procalcitonin (PCT) Assay Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Procalcitonin (PCT) Assay Sales by Country/Region (2021-2026) & (K Tests)
Table 47. Global Procalcitonin (PCT) Assay Sales Market Share by Country/Region (2021-2026)
Table 48. Global Procalcitonin (PCT) Assay Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Procalcitonin (PCT) Assay Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Procalcitonin (PCT) Assay Sales by Country (2021-2026) & (K Tests)
Table 51. Americas Procalcitonin (PCT) Assay Sales Market Share by Country (2021-2026)
Table 52. Americas Procalcitonin (PCT) Assay Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Procalcitonin (PCT) Assay Sales by Type (2021-2026) & (K Tests)
Table 54. Americas Procalcitonin (PCT) Assay Sales by Application (2021-2026) & (K Tests)
Table 55. APAC Procalcitonin (PCT) Assay Sales by Region (2021-2026) & (K Tests)
Table 56. APAC Procalcitonin (PCT) Assay Sales Market Share by Region (2021-2026)
Table 57. APAC Procalcitonin (PCT) Assay Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Procalcitonin (PCT) Assay Sales by Type (2021-2026) & (K Tests)
Table 59. APAC Procalcitonin (PCT) Assay Sales by Application (2021-2026) & (K Tests)
Table 60. Europe Procalcitonin (PCT) Assay Sales by Country (2021-2026) & (K Tests)
Table 61. Europe Procalcitonin (PCT) Assay Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Procalcitonin (PCT) Assay Sales by Type (2021-2026) & (K Tests)
Table 63. Europe Procalcitonin (PCT) Assay Sales by Application (2021-2026) & (K Tests)
Table 64. Middle East & Africa Procalcitonin (PCT) Assay Sales by Country (2021-2026) & (K Tests)
Table 65. Middle East & Africa Procalcitonin (PCT) Assay Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Procalcitonin (PCT) Assay Sales by Type (2021-2026) & (K Tests)
Table 67. Middle East & Africa Procalcitonin (PCT) Assay Sales by Application (2021-2026) & (K Tests)
Table 68. Key Market Drivers & Growth Opportunities of Procalcitonin (PCT) Assay
Table 69. Key Market Challenges & Risks of Procalcitonin (PCT) Assay
Table 70. Key Industry Trends of Procalcitonin (PCT) Assay
Table 71. Procalcitonin (PCT) Assay Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Procalcitonin (PCT) Assay Distributors List
Table 74. Procalcitonin (PCT) Assay Customer List
Table 75. Global Procalcitonin (PCT) Assay Sales Forecast by Region (2027-2032) & (K Tests)
Table 76. Global Procalcitonin (PCT) Assay Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Procalcitonin (PCT) Assay Sales Forecast by Country (2027-2032) & (K Tests)
Table 78. Americas Procalcitonin (PCT) Assay Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Procalcitonin (PCT) Assay Sales Forecast by Region (2027-2032) & (K Tests)
Table 80. APAC Procalcitonin (PCT) Assay Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Procalcitonin (PCT) Assay Sales Forecast by Country (2027-2032) & (K Tests)
Table 82. Europe Procalcitonin (PCT) Assay Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Procalcitonin (PCT) Assay Sales Forecast by Country (2027-2032) & (K Tests)
Table 84. Middle East & Africa Procalcitonin (PCT) Assay Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Procalcitonin (PCT) Assay Sales Forecast by Type (2027-2032) & (K Tests)
Table 86. Global Procalcitonin (PCT) Assay Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Procalcitonin (PCT) Assay Sales Forecast by Application (2027-2032) & (K Tests)
Table 88. Global Procalcitonin (PCT) Assay Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Thermo Fisher Scientific Inc. Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 90. Thermo Fisher Scientific Inc. Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 91. Thermo Fisher Scientific Inc. Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 92. Thermo Fisher Scientific Inc. Main Business
Table 93. Thermo Fisher Scientific Inc. Latest Developments
Table 94. bioM?rieux S.A. Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 95. bioM?rieux S.A. Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 96. bioM?rieux S.A. Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 97. bioM?rieux S.A. Main Business
Table 98. bioM?rieux S.A. Latest Developments
Table 99. F. Hoffmann-La Roche Ltd Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 100. F. Hoffmann-La Roche Ltd Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 101. F. Hoffmann-La Roche Ltd Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 102. F. Hoffmann-La Roche Ltd Main Business
Table 103. F. Hoffmann-La Roche Ltd Latest Developments
Table 104. Fujirebio Inc. Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 105. Fujirebio Inc. Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 106. Fujirebio Inc. Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 107. Fujirebio Inc. Main Business
Table 108. Fujirebio Inc. Latest Developments
Table 109. Abbott Laboratories Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 110. Abbott Laboratories Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 111. Abbott Laboratories Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 112. Abbott Laboratories Main Business
Table 113. Abbott Laboratories Latest Developments
Table 114. Siemens Healthineers Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 115. Siemens Healthineers Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 116. Siemens Healthineers Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 117. Siemens Healthineers Main Business
Table 118. Siemens Healthineers Latest Developments
Table 119. Becton, Dickinson and Company Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 120. Becton, Dickinson and Company Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 121. Becton, Dickinson and Company Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 122. Becton, Dickinson and Company Main Business
Table 123. Becton, Dickinson and Company Latest Developments
Table 124. Danaher Corporation (Beckman Coulter) Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 125. Danaher Corporation (Beckman Coulter) Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 126. Danaher Corporation (Beckman Coulter) Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 127. Danaher Corporation (Beckman Coulter) Main Business
Table 128. Danaher Corporation (Beckman Coulter) Latest Developments
Table 129. Guangzhou Wondfo Biotech Co., Ltd. Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 130. Guangzhou Wondfo Biotech Co., Ltd. Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 131. Guangzhou Wondfo Biotech Co., Ltd. Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 132. Guangzhou Wondfo Biotech Co., Ltd. Main Business
Table 133. Guangzhou Wondfo Biotech Co., Ltd. Latest Developments
Table 134. Getein Biotech, Inc. Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 135. Getein Biotech, Inc. Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 136. Getein Biotech, Inc. Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 137. Getein Biotech, Inc. Main Business
Table 138. Getein Biotech, Inc. Latest Developments
Table 139. Shanghai Outdo Biotech Co., Ltd. Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 140. Shanghai Outdo Biotech Co., Ltd. Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 141. Shanghai Outdo Biotech Co., Ltd. Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 142. Shanghai Outdo Biotech Co., Ltd. Main Business
Table 143. Shanghai Outdo Biotech Co., Ltd. Latest Developments
Table 144. Beijing Biosis Healing Biological Technology Co., Ltd. Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 145. Beijing Biosis Healing Biological Technology Co., Ltd. Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 146. Beijing Biosis Healing Biological Technology Co., Ltd. Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 147. Beijing Biosis Healing Biological Technology Co., Ltd. Main Business
Table 148. Beijing Biosis Healing Biological Technology Co., Ltd. Latest Developments
Table 149. Snibe Diagnostic Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 150. Snibe Diagnostic Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 151. Snibe Diagnostic Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 152. Snibe Diagnostic Main Business
Table 153. Snibe Diagnostic Latest Developments
Table 154. Bioscience (Tianjin) Biotechnology Co., Ltd. Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 155. Bioscience (Tianjin) Biotechnology Co., Ltd. Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 156. Bioscience (Tianjin) Biotechnology Co., Ltd. Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 157. Bioscience (Tianjin) Biotechnology Co., Ltd. Main Business
Table 158. Bioscience (Tianjin) Biotechnology Co., Ltd. Latest Developments
Table 159. Changchun BCHT Biotechnology Co. Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 160. Changchun BCHT Biotechnology Co. Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 161. Changchun BCHT Biotechnology Co. Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 162. Changchun BCHT Biotechnology Co. Main Business
Table 163. Changchun BCHT Biotechnology Co. Latest Developments
Table 164. Ningbo Medicalsystem Biotechnology Co., Ltd. Basic Information, Procalcitonin (PCT) Assay Manufacturing Base, Sales Area and Its Competitors
Table 165. Ningbo Medicalsystem Biotechnology Co., Ltd. Procalcitonin (PCT) Assay Product Portfolios and Specifications
Table 166. Ningbo Medicalsystem Biotechnology Co., Ltd. Procalcitonin (PCT) Assay Sales (K Tests), Revenue ($ Million), Price (US$/Test) and Gross Margin (2021-2026)
Table 167. Ningbo Medicalsystem Biotechnology Co., Ltd. Main Business
Table 168. Ningbo Medicalsystem Biotechnology Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Procalcitonin (PCT) Assay
Figure 2. Procalcitonin (PCT) Assay Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Procalcitonin (PCT) Assay Sales Growth Rate 2021-2032 (K Tests)
Figure 7. Global Procalcitonin (PCT) Assay Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Procalcitonin (PCT) Assay Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Procalcitonin (PCT) Assay Sales Market Share by Country/Region (2025)
Figure 10. Procalcitonin (PCT) Assay Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Serum
Figure 12. Product Picture of Plasma (EDTA/Lithium Heparin)
Figure 13. Product Picture of Whole Blood
Figure 14. Global Procalcitonin (PCT) Assay Sales Market Share by Type in 2026
Figure 15. Global Procalcitonin (PCT) Assay Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Fully Automated (High-Throughput)
Figure 17. Product Picture of Semi-Automated
Figure 18. Product Picture of Manual / Low-Volume
Figure 19. Global Procalcitonin (PCT) Assay Sales Market Share by Automation Level in 2026
Figure 20. Global Procalcitonin (PCT) Assay Revenue Market Share by Automation Level (2021-2026)
Figure 21. Product Picture of Class II (FDA)
Figure 22. Product Picture of Class B/C (IVDR)
Figure 23. Product Picture of Class III (NMPA)
Figure 24. Global Procalcitonin (PCT) Assay Sales Market Share by Regulatory Class in 2026
Figure 25. Global Procalcitonin (PCT) Assay Revenue Market Share by Regulatory Class (2021-2026)
Figure 26. Procalcitonin (PCT) Assay Consumed in Hospital Clinical Laboratories
Figure 27. Global Procalcitonin (PCT) Assay Market: Hospital Clinical Laboratories (2021-2026) & (K Tests)
Figure 28. Procalcitonin (PCT) Assay Consumed in Intensive Care Units (ICUs)
Figure 29. Global Procalcitonin (PCT) Assay Market: Intensive Care Units (ICUs) (2021-2026) & (K Tests)
Figure 30. Procalcitonin (PCT) Assay Consumed in Emergency Departments
Figure 31. Global Procalcitonin (PCT) Assay Market: Emergency Departments (2021-2026) & (K Tests)
Figure 32. Procalcitonin (PCT) Assay Consumed in Reference Laboratories
Figure 33. Global Procalcitonin (PCT) Assay Market: Reference Laboratories (2021-2026) & (K Tests)
Figure 34. Procalcitonin (PCT) Assay Consumed in Point-of-Care Settings
Figure 35. Global Procalcitonin (PCT) Assay Market: Point-of-Care Settings (2021-2026) & (K Tests)
Figure 36. Global Procalcitonin (PCT) Assay Sale Market Share by Application (2025)
Figure 37. Global Procalcitonin (PCT) Assay Revenue Market Share by Application in 2025
Figure 38. Procalcitonin (PCT) Assay Sales by Company in 2025 (K Tests)
Figure 39. Global Procalcitonin (PCT) Assay Sales Market Share by Company in 2025
Figure 40. Procalcitonin (PCT) Assay Revenue by Company in 2025 ($ millions)
Figure 41. Global Procalcitonin (PCT) Assay Revenue Market Share by Company in 2025
Figure 42. Global Procalcitonin (PCT) Assay Sales Market Share by Geographic Region (2021-2026)
Figure 43. Global Procalcitonin (PCT) Assay Revenue Market Share by Geographic Region in 2025
Figure 44. Americas Procalcitonin (PCT) Assay Sales 2021-2026 (K Tests)
Figure 45. Americas Procalcitonin (PCT) Assay Revenue 2021-2026 ($ millions)
Figure 46. APAC Procalcitonin (PCT) Assay Sales 2021-2026 (K Tests)
Figure 47. APAC Procalcitonin (PCT) Assay Revenue 2021-2026 ($ millions)
Figure 48. Europe Procalcitonin (PCT) Assay Sales 2021-2026 (K Tests)
Figure 49. Europe Procalcitonin (PCT) Assay Revenue 2021-2026 ($ millions)
Figure 50. Middle East & Africa Procalcitonin (PCT) Assay Sales 2021-2026 (K Tests)
Figure 51. Middle East & Africa Procalcitonin (PCT) Assay Revenue 2021-2026 ($ millions)
Figure 52. Americas Procalcitonin (PCT) Assay Sales Market Share by Country in 2025
Figure 53. Americas Procalcitonin (PCT) Assay Revenue Market Share by Country (2021-2026)
Figure 54. Americas Procalcitonin (PCT) Assay Sales Market Share by Type (2021-2026)
Figure 55. Americas Procalcitonin (PCT) Assay Sales Market Share by Application (2021-2026)
Figure 56. United States Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 57. Canada Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 58. Mexico Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 59. Brazil Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 60. APAC Procalcitonin (PCT) Assay Sales Market Share by Region in 2025
Figure 61. APAC Procalcitonin (PCT) Assay Revenue Market Share by Region (2021-2026)
Figure 62. APAC Procalcitonin (PCT) Assay Sales Market Share by Type (2021-2026)
Figure 63. APAC Procalcitonin (PCT) Assay Sales Market Share by Application (2021-2026)
Figure 64. China Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 65. Japan Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 66. South Korea Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 67. Southeast Asia Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 68. India Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 69. Australia Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 70. China Taiwan Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 71. Europe Procalcitonin (PCT) Assay Sales Market Share by Country in 2025
Figure 72. Europe Procalcitonin (PCT) Assay Revenue Market Share by Country (2021-2026)
Figure 73. Europe Procalcitonin (PCT) Assay Sales Market Share by Type (2021-2026)
Figure 74. Europe Procalcitonin (PCT) Assay Sales Market Share by Application (2021-2026)
Figure 75. Germany Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 76. France Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 77. UK Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 78. Italy Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 79. Russia Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 80. Middle East & Africa Procalcitonin (PCT) Assay Sales Market Share by Country (2021-2026)
Figure 81. Middle East & Africa Procalcitonin (PCT) Assay Sales Market Share by Type (2021-2026)
Figure 82. Middle East & Africa Procalcitonin (PCT) Assay Sales Market Share by Application (2021-2026)
Figure 83. Egypt Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 84. South Africa Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 85. Israel Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 86. Turkey Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 87. GCC Countries Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 88. Manufacturing Cost Structure Analysis of Procalcitonin (PCT) Assay in 2026
Figure 89. Manufacturing Process Analysis of Procalcitonin (PCT) Assay
Figure 90. Industry Chain Structure of Procalcitonin (PCT) Assay
Figure 91. Channels of Distribution
Figure 92. Global Procalcitonin (PCT) Assay Sales Market Forecast by Region (2027-2032)
Figure 93. Global Procalcitonin (PCT) Assay Revenue Market Share Forecast by Region (2027-2032)
Figure 94. Global Procalcitonin (PCT) Assay Sales Market Share Forecast by Type (2027-2032)
Figure 95. Global Procalcitonin (PCT) Assay Revenue Market Share Forecast by Type (2027-2032)
Figure 96. Global Procalcitonin (PCT) Assay Sales Market Share Forecast by Application (2027-2032)
Figure 97. Global Procalcitonin (PCT) Assay Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Procalcitonin (PCT) Assay
Figure 2. Procalcitonin (PCT) Assay Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Procalcitonin (PCT) Assay Sales Growth Rate 2021-2032 (K Tests)
Figure 7. Global Procalcitonin (PCT) Assay Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Procalcitonin (PCT) Assay Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Procalcitonin (PCT) Assay Sales Market Share by Country/Region (2025)
Figure 10. Procalcitonin (PCT) Assay Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Serum
Figure 12. Product Picture of Plasma (EDTA/Lithium Heparin)
Figure 13. Product Picture of Whole Blood
Figure 14. Global Procalcitonin (PCT) Assay Sales Market Share by Type in 2026
Figure 15. Global Procalcitonin (PCT) Assay Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Fully Automated (High-Throughput)
Figure 17. Product Picture of Semi-Automated
Figure 18. Product Picture of Manual / Low-Volume
Figure 19. Global Procalcitonin (PCT) Assay Sales Market Share by Automation Level in 2026
Figure 20. Global Procalcitonin (PCT) Assay Revenue Market Share by Automation Level (2021-2026)
Figure 21. Product Picture of Class II (FDA)
Figure 22. Product Picture of Class B/C (IVDR)
Figure 23. Product Picture of Class III (NMPA)
Figure 24. Global Procalcitonin (PCT) Assay Sales Market Share by Regulatory Class in 2026
Figure 25. Global Procalcitonin (PCT) Assay Revenue Market Share by Regulatory Class (2021-2026)
Figure 26. Procalcitonin (PCT) Assay Consumed in Hospital Clinical Laboratories
Figure 27. Global Procalcitonin (PCT) Assay Market: Hospital Clinical Laboratories (2021-2026) & (K Tests)
Figure 28. Procalcitonin (PCT) Assay Consumed in Intensive Care Units (ICUs)
Figure 29. Global Procalcitonin (PCT) Assay Market: Intensive Care Units (ICUs) (2021-2026) & (K Tests)
Figure 30. Procalcitonin (PCT) Assay Consumed in Emergency Departments
Figure 31. Global Procalcitonin (PCT) Assay Market: Emergency Departments (2021-2026) & (K Tests)
Figure 32. Procalcitonin (PCT) Assay Consumed in Reference Laboratories
Figure 33. Global Procalcitonin (PCT) Assay Market: Reference Laboratories (2021-2026) & (K Tests)
Figure 34. Procalcitonin (PCT) Assay Consumed in Point-of-Care Settings
Figure 35. Global Procalcitonin (PCT) Assay Market: Point-of-Care Settings (2021-2026) & (K Tests)
Figure 36. Global Procalcitonin (PCT) Assay Sale Market Share by Application (2025)
Figure 37. Global Procalcitonin (PCT) Assay Revenue Market Share by Application in 2025
Figure 38. Procalcitonin (PCT) Assay Sales by Company in 2025 (K Tests)
Figure 39. Global Procalcitonin (PCT) Assay Sales Market Share by Company in 2025
Figure 40. Procalcitonin (PCT) Assay Revenue by Company in 2025 ($ millions)
Figure 41. Global Procalcitonin (PCT) Assay Revenue Market Share by Company in 2025
Figure 42. Global Procalcitonin (PCT) Assay Sales Market Share by Geographic Region (2021-2026)
Figure 43. Global Procalcitonin (PCT) Assay Revenue Market Share by Geographic Region in 2025
Figure 44. Americas Procalcitonin (PCT) Assay Sales 2021-2026 (K Tests)
Figure 45. Americas Procalcitonin (PCT) Assay Revenue 2021-2026 ($ millions)
Figure 46. APAC Procalcitonin (PCT) Assay Sales 2021-2026 (K Tests)
Figure 47. APAC Procalcitonin (PCT) Assay Revenue 2021-2026 ($ millions)
Figure 48. Europe Procalcitonin (PCT) Assay Sales 2021-2026 (K Tests)
Figure 49. Europe Procalcitonin (PCT) Assay Revenue 2021-2026 ($ millions)
Figure 50. Middle East & Africa Procalcitonin (PCT) Assay Sales 2021-2026 (K Tests)
Figure 51. Middle East & Africa Procalcitonin (PCT) Assay Revenue 2021-2026 ($ millions)
Figure 52. Americas Procalcitonin (PCT) Assay Sales Market Share by Country in 2025
Figure 53. Americas Procalcitonin (PCT) Assay Revenue Market Share by Country (2021-2026)
Figure 54. Americas Procalcitonin (PCT) Assay Sales Market Share by Type (2021-2026)
Figure 55. Americas Procalcitonin (PCT) Assay Sales Market Share by Application (2021-2026)
Figure 56. United States Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 57. Canada Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 58. Mexico Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 59. Brazil Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 60. APAC Procalcitonin (PCT) Assay Sales Market Share by Region in 2025
Figure 61. APAC Procalcitonin (PCT) Assay Revenue Market Share by Region (2021-2026)
Figure 62. APAC Procalcitonin (PCT) Assay Sales Market Share by Type (2021-2026)
Figure 63. APAC Procalcitonin (PCT) Assay Sales Market Share by Application (2021-2026)
Figure 64. China Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 65. Japan Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 66. South Korea Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 67. Southeast Asia Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 68. India Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 69. Australia Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 70. China Taiwan Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 71. Europe Procalcitonin (PCT) Assay Sales Market Share by Country in 2025
Figure 72. Europe Procalcitonin (PCT) Assay Revenue Market Share by Country (2021-2026)
Figure 73. Europe Procalcitonin (PCT) Assay Sales Market Share by Type (2021-2026)
Figure 74. Europe Procalcitonin (PCT) Assay Sales Market Share by Application (2021-2026)
Figure 75. Germany Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 76. France Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 77. UK Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 78. Italy Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 79. Russia Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 80. Middle East & Africa Procalcitonin (PCT) Assay Sales Market Share by Country (2021-2026)
Figure 81. Middle East & Africa Procalcitonin (PCT) Assay Sales Market Share by Type (2021-2026)
Figure 82. Middle East & Africa Procalcitonin (PCT) Assay Sales Market Share by Application (2021-2026)
Figure 83. Egypt Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 84. South Africa Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 85. Israel Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 86. Turkey Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 87. GCC Countries Procalcitonin (PCT) Assay Revenue Growth 2021-2026 ($ millions)
Figure 88. Manufacturing Cost Structure Analysis of Procalcitonin (PCT) Assay in 2026
Figure 89. Manufacturing Process Analysis of Procalcitonin (PCT) Assay
Figure 90. Industry Chain Structure of Procalcitonin (PCT) Assay
Figure 91. Channels of Distribution
Figure 92. Global Procalcitonin (PCT) Assay Sales Market Forecast by Region (2027-2032)
Figure 93. Global Procalcitonin (PCT) Assay Revenue Market Share Forecast by Region (2027-2032)
Figure 94. Global Procalcitonin (PCT) Assay Sales Market Share Forecast by Type (2027-2032)
Figure 95. Global Procalcitonin (PCT) Assay Revenue Market Share Forecast by Type (2027-2032)
Figure 96. Global Procalcitonin (PCT) Assay Sales Market Share Forecast by Application (2027-2032)
Figure 97. Global Procalcitonin (PCT) Assay Revenue Market Share Forecast by Application (2027-2032)
